These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dose-rate effects between 0.3 and 30 Gy/h in a normal and a malignant human cell line. Amdur RJ, Bedford JS. Int J Radiat Oncol Biol Phys; 1994 Aug 30; 30(1):83-90. PubMed ID: 8083132 [Abstract] [Full Text] [Related]
7. Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme. Taghian A, Ramsay J, Allalunis-Turner J, Budach W, Gioioso D, Pardo F, Okunieff P, Bleehen N, Urtasun R, Suit H. Int J Radiat Oncol Biol Phys; 1993 Jan 15; 25(2):243-9. PubMed ID: 8380568 [Abstract] [Full Text] [Related]
8. Response of human tumor cell lines in vitro to fractionated irradiation. Matthews JH, Meeker BE, Chapman JD. Int J Radiat Oncol Biol Phys; 1989 Jan 15; 16(1):133-8. PubMed ID: 2912934 [Abstract] [Full Text] [Related]
9. Recovery from sublethal damage during intermittent exposures in cultured tumor cells: implications for dose modification in radiosurgery and IMRT. Shibamoto Y, Ito M, Sugie C, Ogino H, Hara M. Int J Radiat Oncol Biol Phys; 2004 Aug 01; 59(5):1484-90. PubMed ID: 15275736 [Abstract] [Full Text] [Related]
10. Development of an in vitro chemo-radiation response assay for cervical carcinoma. Monk BJ, Burger RA, Parker R, Radany EH, Redpath L, Fruehauf JP. Gynecol Oncol; 2002 Nov 01; 87(2):193-9. PubMed ID: 12477451 [Abstract] [Full Text] [Related]
11. Comparison of high dose rate, low dose rate, and high dose rate fractionated radiation for optimizing differences in radiosensitivities in vitro. Wilkins RC, Ng CE, Raaphorst GP. Radiat Oncol Investig; 1998 Nov 01; 6(5):209-15. PubMed ID: 9822167 [Abstract] [Full Text] [Related]
12. The effects of altered fractionation schedules on the survival of human cell lines differing in their proliferative activity and repair capacity. Konefal JB, Taylor YC. Int J Radiat Oncol Biol Phys; 1989 Nov 01; 17(5):1007-13. PubMed ID: 2808033 [Abstract] [Full Text] [Related]
14. The reproducibility and relationship between single and fractionated dose estimates of the surviving fraction at 2 Gy. Gerweck LE, Zaidi ST. Int J Radiat Oncol Biol Phys; 1996 Apr 01; 35(1):81-7. PubMed ID: 8641930 [Abstract] [Full Text] [Related]
16. Potential application of the ATP cell viability assay in the measurement of intrinsic radiosensitivity in cervical cancer. Tam KF, Ng TY, Liu SS, Tsang PC, Kwong PW, Ngan HY. Gynecol Oncol; 2005 Mar 01; 96(3):765-70. PubMed ID: 15721424 [Abstract] [Full Text] [Related]
17. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma. Lee SW, Suh CO, Chung EJ, Kim GE. Int J Radiat Oncol Biol Phys; 2002 Apr 01; 52(5):1338-44. PubMed ID: 11955747 [Abstract] [Full Text] [Related]
18. Discrimination of human tumor radioresponsiveness using low-dose rate irradiation. Björk-Eriksson T, West C, Karlsson E, Mercke C. Int J Radiat Oncol Biol Phys; 1998 Dec 01; 42(5):1147-53. PubMed ID: 9869242 [Abstract] [Full Text] [Related]
19. Equivalence of pulsed-dose-rate to low-dose-rate irradiation in tumor and normal cell lines. Niedbala M, Alsbeih G, Ng CE, Raaphorst GP. Radiat Res; 2001 Feb 01; 155(2):297-303. PubMed ID: 11175664 [Abstract] [Full Text] [Related]
20. Single-dose and fractionated irradiation of four human lung cancer cell lines in vitro. Brodin O, Lennartsson L, Nilsson S. Acta Oncol; 1991 Feb 01; 30(8):967-74. PubMed ID: 1663776 [Abstract] [Full Text] [Related] Page: [Next] [New Search]